Are fibrinaloid microclots a cause of autoimmunity in Long Covid and other post-infection diseases?

DB Kell, E Pretorius - Biochemical Journal, 2023 - portlandpress.com
It is now well established that the blood-clotting protein fibrinogen can polymerise into an
anomalous form of fibrin that is amyloid in character; the resultant clots and microclots entrap …

Aggregation behavior of nanoparticles: Revisiting the phase diagram of colloids

M Bini, G Brancolini, V Tozzini - Frontiers in Molecular Biosciences, 2022 - frontiersin.org
Surface functionalization of metal nanoparticles (NPs), eg, using peptides and proteins, has
recently attracted a considerable attention in the field of design of therapeutics and …

The ribosome stabilizes partially folded intermediates of a nascent multi-domain protein

SHS Chan, T Włodarski, JO Streit, AME Cassaignau… - Nature …, 2022 - nature.com
Co-translational folding is crucial to ensure the production of biologically active proteins. The
ribosome can alter the folding pathways of nascent polypeptide chains, yet a structural …

The Extracts of Polygonum cuspidatum Root and Rhizome Block the Entry of SARS-CoV-2 Wild-Type and Omicron Pseudotyped Viruses via Inhibition of the S …

S Lin, X Wang, RWL Tang, HC Lee, HH Chan… - Molecules, 2022 - mdpi.com
COVID-19, resulting from infection by the SARS-CoV-2 virus, caused a contagious
pandemic. Even with the current vaccines, there is still an urgent need to develop effective …

Mechanistic analysis of Riboswitch Ligand interactions provides insights into pharmacological control over gene expression

S Parmar, DD Bume, CM Connelly, RE Boer… - Nature …, 2024 - nature.com
Riboswitches are structured RNA elements that regulate gene expression upon binding to
small molecule ligands. Understanding the mechanisms by which small molecules impact …

Update on a brain-penetrant cardiac glycoside that can lower cellular prion protein levels in human and guinea pig paradigms

S Eid, W Zhao, D Williams, Z Nasser, J Griffin… - PLoS …, 2024 - journals.plos.org
Lowering the levels of the cellular prion protein (PrPC) is widely considered a promising
strategy for the treatment of prion diseases. Building on work that established immediate …

Innovative non-PrP-targeted drug strategy designed to enhance prion clearance

A Colini Baldeschi, M Zattoni, S Vanni… - Journal of medicinal …, 2022 - ACS Publications
Prion diseases are a group of neurodegenerative disorders characterized by the
accumulation of misfolded prion protein (called PrPSc). Although conversion of the cellular …

Pliability in the m6A-Binding Region Extends Druggability of YTH Domains

G Cazzanelli, A Dalle Vedove, G Spagnolli… - Journal of Chemical …, 2024 - ACS Publications
Epitranscriptomic mRNA modifications affect gene expression, with their altered balance
detected in various cancers. YTHDF proteins contain the YTH reader domain recognizing …

Drug design: where we are and future prospects

G Zagotto, M Bortoli - Molecules, 2021 - mdpi.com
Medicinal chemistry is facing new challenges in approaching precision medicine. Several
powerful new tools or improvements of already used tools are now available to medicinal …

Polygoni multiflori radix extracts inhibit SARS-CoV-2 pseudovirus entry in HEK293T cells and zebrafish larvae

X Wang, S Lin, RWL Tang, HC Lee, HH Chan… - Phytomedicine, 2022 - Elsevier
Background Globally, COVID-19 has caused millions of deaths and led to unprecedented
socioeconomic damage. There is therefore, in addition to vaccination, an urgent need to …